Emilie Chalayer
8PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 14, 2025
Thromboelastometric assessment of the haemostatic effect of tranexamic acid as an adjunct to prophylactic platelet transfusions in patients with haematological malignancies undergoing intensive chemotherapy: A pilot study.Guillaume Simoens, Elisabeth Daguenet, Audrey Tientcheu
|Mar 17, 2025
Management of thrombocytopenia and anticoagulant therapy in patients with hematological malignancy on chemotherapy: a binational prospective study (TAT study).Elie Jalaber, Corentin Orvain, Vasiliki Papadopoulou
|May 13, 2022
Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: Lessons from the substudy of IFM/DFCI 2009 cohort.Emilie Chalayer, Alexis Talbot, Laurent Frenzel
|Nov 24, 2021
Management of bone marrow biopsy related bleeding risks: a retrospective observational study.Lucile Grange, Martin Killian, Emmanuelle Tavernier
|Oct 17, 2019
Predicting the risk of venous thromboembolism in newly diagnosed myeloma with immunomodulatory drugs: External validation of the IMPEDE VTE score.Emilie Chalayer, Alice Teste, Denis Guyotat
|Aug 13, 2019
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC.Bernard Tardy, Emilie Chalayer, Pieter Willem Kamphuisen
Pageof 2
